Memos
Epstein Barr Virus PCR Quantitative, Plasma – Updated Methodology
08.13.2026
Effective immediately, the methodology for Epstein Barr Virus PCR Quantitative, Plasma testing has changed from the Altona method to the Roche Cobas® 6800 platform.
New Test Offerings
New Test: Thiocyanate, Serum/Plasma
08.13.2026
Thiocyanate, Serum/Plasma is now available at University Health Network, Toronto.
Test Updates
UPDATE: Fluoxetine and Metabolite, Serum/Plasma – Change in Methodology
07.24.2026
Following updates to Fluoxetine and Metabolite, Serum/Plasma methodology, please note changes in reference ranges and HL7 order codes.
Test Updates
Vascular Endothelial Growth Factor D (VEGFD), Serum/Plasma – Reference Interval Update
07.16.2026
Effective immediately, Cincinnati Children’s Hospital has transitioned to a new testing platform for Vascular Endothelial Growth Factor D (VEGFD), Serum/Plasma testing.
Test Updates
Neurofilament Light Chain (NfL), Serum/Plasma – Z-score Reporting and Reference Interval Update
06.26.2026
Effective immediately, EORLA (Ottawa Hospital General Campus) will be including Z-scores with all results for Neurofilament Light Chain (NfL), Serum/Plasma in adults.
Test Updates
Fluoxetine and Metabolite, Serum/Plasma – Change in Methodology
06.24.2026
Effective immediately, the methodology has changed to ultra-performance liquid chromatography with tandem mass spectrometry detection.
New Test Offerings
New Test Listing – pTau217 by ECLIA
06.16.2026
ICL now offers two pTau217 assays by two different methodologies: SiMoa and ECLIA.